Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALK33-001: A Phase 1 Study of the Pharmacokinetics of RDC-0313 Administered to Healthy Adults

NCT00800319 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.

NCT NCT00800319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00800319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALK33-001: A Phase 1 Study of the Pharmacokinetics of RDC-0313 Administered to Healthy Adults
Lead sponsor
Alkermes, Inc.
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2008
Completion date
June 30, 2009
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence